
James H. Reamer
Examiner (ID: 10116)
| Most Active Art Unit | 1206 |
| Art Unit(s) | 1206, 1205, 1614, 3106, 2899, 2746 |
| Total Applications | 2884 |
| Issued Applications | 2358 |
| Pending Applications | 157 |
| Abandoned Applications | 369 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17982512
[patent_doc_number] => 20220348548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Composition of 5-Fluorouracil and Refining Method Therefor
[patent_app_type] => utility
[patent_app_number] => 17/629777
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629777 | Composition of 5-fluorouracil and refining method therefor | Jan 9, 2020 | Issued |
Array
(
[id] => 17905462
[patent_doc_number] => 11459305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Processes for the preparation of uracil derivatives
[patent_app_type] => utility
[patent_app_number] => 16/739263
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7210
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739263 | Processes for the preparation of uracil derivatives | Jan 9, 2020 | Issued |
Array
(
[id] => 15828473
[patent_doc_number] => 20200129518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE MODULATORS OF GPR139
[patent_app_type] => utility
[patent_app_number] => 16/732536
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732536
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/732536 | 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139 | Jan 1, 2020 | Issued |
Array
(
[id] => 15831653
[patent_doc_number] => 20200131108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYLOPENTYL ACETIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/731705
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 433
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/731705 | Method for synthesizing novel compounds derived from 3-hydroxy-cylopentyl acetic acid | Dec 30, 2019 | Issued |
Array
(
[id] => 15831835
[patent_doc_number] => 20200131199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 16/731277
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/731277 | Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same | Dec 30, 2019 | Issued |
Array
(
[id] => 16504726
[patent_doc_number] => 20200383982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/724827
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724827 | PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS | Dec 22, 2019 | Abandoned |
Array
(
[id] => 16443630
[patent_doc_number] => 10835534
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Compounds
[patent_app_type] => utility
[patent_app_number] => 16/725709
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18926
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725709 | Compounds | Dec 22, 2019 | Issued |
Array
(
[id] => 18102365
[patent_doc_number] => 11542240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => STK19 inhibitors for treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/722224
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 112
[patent_no_of_words] => 41598
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/722224 | STK19 inhibitors for treatment of cancer | Dec 19, 2019 | Issued |
Array
(
[id] => 17634994
[patent_doc_number] => 11345707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Atropisomerism for increased kinase inhibitor selectivity
[patent_app_type] => utility
[patent_app_number] => 16/719379
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 14786
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719379 | Atropisomerism for increased kinase inhibitor selectivity | Dec 17, 2019 | Issued |
Array
(
[id] => 18289884
[patent_doc_number] => 11618746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-04
[patent_title] => Inhibitors of APOL1 and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/717099
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 79993
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717099 | Inhibitors of APOL1 and methods of using same | Dec 16, 2019 | Issued |
Array
(
[id] => 18385605
[patent_doc_number] => 11656384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Composition, film, lens, solid state imaging element, and compounds
[patent_app_type] => utility
[patent_app_number] => 16/713234
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24472
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713234 | Composition, film, lens, solid state imaging element, and compounds | Dec 12, 2019 | Issued |
Array
(
[id] => 17922755
[patent_doc_number] => 11465988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Process for the preparation of Tipiracil hydrochloride and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 17/418752
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2869
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418752 | Process for the preparation of Tipiracil hydrochloride and intermediates thereof | Dec 12, 2019 | Issued |
Array
(
[id] => 15866067
[patent_doc_number] => 20200140437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => QUINAZOLINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/712018
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712018 | Quinazoline compound | Dec 11, 2019 | Issued |
Array
(
[id] => 15768659
[patent_doc_number] => 20200115347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/710373
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710373 | DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS | Dec 10, 2019 | Abandoned |
Array
(
[id] => 19456727
[patent_doc_number] => 12097195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Pharmaceutical composition containing alkynyl compound and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/259719
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5938
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259719 | Pharmaceutical composition containing alkynyl compound and preparation method and application thereof | Dec 8, 2019 | Issued |
Array
(
[id] => 16321254
[patent_doc_number] => 10781210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity
[patent_app_type] => utility
[patent_app_number] => 16/684807
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30112
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 939
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/684807 | Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity | Nov 14, 2019 | Issued |
Array
(
[id] => 17335922
[patent_doc_number] => 20220002253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHOD FOR PRODUCING OROTIC ACID DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/291662
[patent_app_country] => US
[patent_app_date] => 2019-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291662 | Method for producing orotic acid derivative | Nov 6, 2019 | Issued |
Array
(
[id] => 17421203
[patent_doc_number] => 11254644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
[patent_app_type] => utility
[patent_app_number] => 16/670676
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 41735
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670676
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/670676 | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase | Oct 30, 2019 | Issued |
Array
(
[id] => 16253440
[patent_doc_number] => 20200262814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/666108
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666108
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/666108 | Protein kinase C inhibitors and methods of their use | Oct 27, 2019 | Issued |
Array
(
[id] => 15799983
[patent_doc_number] => 20200123134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => PYRIDAZINONES AS PARP7 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/662409
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 145646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/662409 | Pyridazinones as PARP7 inhibitors | Oct 23, 2019 | Issued |